<- Go Home
CareFusion 303, Inc.
CareFusion 303, Inc. designs, manufactures, distributes, and services intravenous infusion therapy and patient monitoring instruments and related disposables, accessories, and services. The company offers IV medication safety and infusion therapy delivery systems, software applications, needle-free disposables, and related patient monitoring equipment. Its IV infusion systems are used to deliver to patients one or more fluids, primarily pharmaceuticals or nutritionals, and consist of medication safety systems, single and multichannel infusion pumps, syringe pumps, and dedicated and nondedicated disposable administration sets. The company's Medley Medication Safety System enables to gather and record clinical information for review, analysis, and interpretation. In addition, it offers patient monitoring products that measure and monitor temperature, pulse oximetry, and blood pressure. It offers its products and services to hospitals, health care systems, and alternative care sites internationally through direct sales force and distributors. CareFusion 303, Inc. was formerly known as Cardinal Health 303, Inc. and changed its name to CareFusion 303, Inc. in August 2007. The company was incorporated in 1988 and is based in San Diego, California. CareFusion 303, Inc. operates as a subsidiary of Becton, Dickinson and Company.
Market Cap
$1.6B
Volume
199.1K
Cash and Equivalents
$31.7M
EBITDA
$128.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$297.9M
Profit Margin
54.47%
52 Week High
$23.00
52 Week Low
$12.62
Dividend
N/A
Price / Book Value
14.76
Price / Earnings
964.09
Price / Tangible Book Value
-12.92
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$100.9M
Return on Equity
3.95%
Return on Assets
11.14
Cash and Short Term Investments
$31.7M
Debt
$338.2M
Equity
$108.0M
Revenue
$546.9M
Unlevered FCF
$32.8M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium